Tuesday , September 21 2021

The European Commission has approved a contract with NovaVax for 200 million vaccine medicines



Under this agreement, EU members will be able to purchase 100 million of NovaVax’s medicines, with the option to add four million in the fourth quarter of 2021 and 100 million additional medicines in 2022 and 2023.

As new variants of the Corona virus are spreading throughout Europe and around the world, this new deal with a company that has successfully tested its formulation to provide additional protection for our population against these variants. This additionally strengthens our broad portfolio of vaccines, benefiting our partners across Europe and Europe – commenting on the outcome of the agreement with Ursula van der Lein, president of the European Commission.

How long does Paul live? What caused the death New GUS Report

The European Medicines Agency (EMA) is still reviewing Novavax before it was allowed on the EU market. The preparation of the US company is on a single protein and works in the same way as the known ethanol vaccine against hepatitis B or tetanus. No medication required.

Novovax vaccine will also be produced in Poland by near Mabion near neard.


PAP




Source link